Non-Hodgkin lymphoma (NHL) Treatment in United Arab Emirates

What is Non-Hodgkin lymphoma (NHL)?

Non-Hodgkin lymphoma is a kind of cancer affecting the lymphatic system. The lymphatic system comprises organs, glands, tube-like channels, and lymph node clusters. It is a component of the body's germ-fighting immune system.

Non-Hodgkin lymphoma develops when germ-fighting cells in the lymphatic system become out of control. Tumors are growths that cells can generate throughout the body.

What is the Importance of Timely Treatment?

• Non-Hodgkin lymphoma (NHL) should be treated immediately to improve patient outcomes. Early management helps to keep the condition from developing to later stages, which can be more challenging to treat.
• NHL has considerably better survival rates when discovered and treated early since patients are more likely to respond successfully to medicines, including chemotherapy, immunotherapy, and targeted treatments.
• Delays in therapy might result in problems such as organ damage and increased tumour growth, lowering the likelihood of successful management.
• Timely NHL treatment increases the chances of remission, reduces complications, and improves overall quality of life.

What are the Common Symptoms of Non-Hodgkin lymphoma (NHL)?

Non-Hodgkin lymphoma symptoms may include the following:

• Swollen lymph nodes in the neck, armpits, or groin
• Persistent exhaustion
• Chest discomfort
• Cough
• Difficulty breathing (dyspnea)
• Abdominal discomfort or oedema
• Symptoms may include feeling full despite not having eaten
• Unexplained temperature.
• Drenching night sweats.
• Unexplained weight loss

Types of Non-Hodgkin lymphoma (NHL)

Non-Hodgkin lymphoma can be classified into over 70 different subgroups. Healthcare practitioners categorise them according to the type of lymphocyte affected:

• B cell lymphoma: B cells are a type of lymphocyte that helps fight infection. B cells produce antibodies against foreign invaders. B cells are responsible for the vast majority of non-Hodgkin lymphomas. Non-Hodgkin lymphoma subtypes involving B cells include diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and Burkitt lymphoma.
• T cell lymphoma: T cells are lymphocytes that destroy foreign invaders directly. Non-Hodgkin lymphoma occurs substantially less frequently in T cells. Peripheral T-cell lymphoma and cutaneous T-cell lymphoma are two T-cell-related non-Hodgkin lymphoma subtypes.

Stages of Non-Hodgkin lymphoma (NHL)

Healthcare providers stage cancer to design treatment strategies and predict prognosis, which is the expected outcome. Non-Hodgkin lymphoma stages are as follows:

• Stage I: Cancer cells are seen in one lymph node or lymphoid organ. Or there is lymphoma in a specific location of a particular organ outside your lymphatic system.
• Stage II: Lymphoma exists in two or more groups of lymph nodes on the same side of (or near) your diaphragm.
• Stage III: Cancer cells are found in lymph node locations above and below your diaphragm or lymph nodes above your diaphragm and in your spleen.
• Stage IV: At least one organ outside your lymph system, such as your liver or lungs, has extensive lymphoma.

Causes, Risk Factors and Complications of Non-Hodgkin Lymphoma (NHL)

Causes

• Non-Hodgkin lymphomas develop when your body creates an excess of lymphocytes. These comprise B cells, T cells, and (occasionally) natural killer (NK) cells. Acquired genetic alterations that influence lymphocyte development contribute to the process.
• When lymphocytes mutate, they multiply and eventually become tumours. Usually, cancers begin in your lymph nodes. Because the lymphatic system contacts almost every body region, non-Hodgkin lymphoma frequently spreads to other lymph organs.

Risk Factors

The following factors may increase the risk of non-Hodgkin lymphoma:

• Medicines that reduce immune response: Following an organ transplant, taking immune-modulating medications may increase the risk of non-Hodgkin lymphoma.
• Infection with certain viruses and bacteria: A few infections appear to increase the risk of non-Hodgkin lymphoma.
• Chemicals: Certain chemicals, such as those used to eliminate insects and weeds, can increase the risk of non-Hodgkin lymphoma.
• Older age: Non-Hodgkin lymphoma can develop at any age. However, it is more common among those aged 60 and up.

Complications

Non-Hodgkin lymphoma and its therapies can induce a variety of problems, including:

• Weakened immune system.
• Fertility problems
• Secondary Cancer
• Organ Damage

Latest Research and Technologies in the Treatment of Non-Hodgkin Lymphoma (NHL) in the United Arab Emirates

• For patients with relapsed or refractory non-Hodgkin lymphoma who are unable to receive stem cell transplantation, radioimmunotherapy has become a potentially effective treatment option. It has demonstrated positive benefits, including better survival rates and acceptable safety profiles.
• Targeted Therapies: When used in conjunction with conventional treatments, targeted therapies, such as antibody-drug conjugates, are increasing the efficacy of treatment for aggressive forms of non-Hodgkin lymphoma by providing higher response rates and progression-free survival.

Non-Hodgkin Lymphoma (NHL) Prevention Tips

Some preventative tips for non-Hodgkin lymphoma (NHL):

• Prevent exposure to hazardous chemicals.
• Reduce radiation exposure from unneeded medical imaging and workplace settings.
• Improve immunological health by eating a well-balanced diet, exercising regularly, and managing stress.
• Prevent infection.
• To lower the risk of NHL, limit your alcohol consumption.
• To support immune function, eat a nutritious diet that includes fruits, vegetables, and whole grains.
• These steps can help lower risk, but frequent health screenings are necessary for early detection.